ArticlePloS one2026
Effect of a freeze-thaw cycle on amniotic fluid interleukin-6 concentrations in pregnancies with preterm prelabor rupture of membranes: Implications for the diagnosis of intra-amniotic inflammation.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePreterm prelabor rupture of membranes (PPROM) is frequently complicated by intra-amniotic inflammation. Interleukin-6 (IL-6) measured in amniotic fluid is considered the gold-standard biomarker for the diagnosis of this condition; however, diagnostic thresholds have been derived primarily from biobanked samples. It remains unclear whether IL-6 concentrations measured in fresh amniotic fluid are directly comparable with those obtained from previously processed samples. The primary aim of this study was to compare IL-6 concentrations in fresh amniotic fluid samples with those in biobanked samples that had undergone a single freeze-thaw cycle.
methodThis retrospective study included consecutive singleton pregnancies with PPROM between 24 + 0 and 36 + 6 weeks of gestation. Amniotic fluid samples were collected on admission, prior to the administration of antibiotics and corticosteroids. IL-6 concentrations were measured in both fresh and biobanked (processed) samples using an automated electrochemiluminescence immunoassay.
resultsThe study population comprised 152 women. IL-6 concentrations in fresh and processed samples were strongly correlated (rho = 0.97; p < 0.0001). Bland-Altman analysis demonstrated a systematic bias toward higher concentrations in processed samples, with a mean ratio of 1.2, indicating that processed samples yielded on average approximately 20% higher values than fresh samples. When applying the validated diagnostic threshold of 3,000 pg/mL (established in processed samples) to fresh samples, three false-negative cases were observed. In these cases, intra-amniotic inflammation was present, but IL-6 concentrations in fresh samples were below the threshold despite corresponding processed values ≥ 3,000 pg/mL. Using intra-amniotic inflammation defined by processed samples as the reference, the diagnostic performance of the 3,000 pg/mL threshold applied to fresh samples was as follows: sensitivity 92%, specificity 100%, positive predictive value 100%, and negative predictive value 97%.
conclusionsIL-6 concentrations in fresh and processed amniotic fluid samples are highly correlated, but processed samples consistently yield higher values.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.